Left Ventricular Mass: Reliability of M-Mode and 2-Dimensional Echocardiographic Formulas

Abstract—The study of left ventricular (LV) hypertrophy is hindered by problems with LV mass measurement by echocardiography. Both the M-mode and 2D area-length formulas for calculating LV mass assume a fixed geometric shape, which may be a source of error. We examined this hypothesis by using cardiovascular magnetic resonance images to eliminate the confounding effects of acoustic access and image quality. LV mass was measured directly in 212 healthy subjects by means of a standard 3D cardiovascular magnetic resonance technique. LV mass was also calculated by using the cube-function and area-length formulas with measurements from the magnetic resonance images. A comparison of serial measurements was made by examining the changes in LV mass by all 3 techniques in those completing an exercise program (n=140). The cube-function technique showed a consistent underestimation of LV mass of 14.3 g, and there were wide 95% limits of agreement (±57.6 g and ±46.3 g for cube-function and area-length techniques, respectively) when compared with 3D measurement. There were similarly wide limits of agreement for the change in mass (±55.2 g and ±44.8 g for cube-function and area-length, respectively). The assumption of geometric shape in the cube-function and area-length formulas resulted in significant variation in LV mass estimates from direct measurement by using a 3D technique. The technique cannot be recommended either at a single time point or for serial studies in small populations; 3D imaging techniques, such as cardiovascular magnetic resonance, are preferable.

[1]  N. Silverman,et al.  Accuracy and reproducibility of clinically acquired two-dimensional echocardiographic mass measurements. , 1989, American heart journal.

[2]  J. Gottdiener,et al.  Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. , 1995, Journal of the American College of Cardiology.

[3]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[4]  B Kastler,et al.  Inter-study variability in left ventricular mass measurement. Comparison between M-mode echography and MRI. , 1992, European heart journal.

[5]  J. Hestenes,et al.  Cross‐sectional Echocardiography 1. Analysis of Mathematic Models for Quantifying Mass of the Left Ventricle in Dogs , 1979, Circulation.

[6]  N. Reichek,et al.  Anatomic Validation of Left Ventricular Mass Estimates from Clinical Two‐dimensional Echocardiography: Initial Results , 1983, Circulation.

[7]  A. Weyman Cross-sectional echocardiography , 1982 .

[8]  D. Levy,et al.  Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. , 1994, Circulation.

[9]  R W Parkey,et al.  Estimation of human myocardial mass with MR imaging. , 1988, Radiology.

[10]  D. King,et al.  Freehand three-dimensional echocardiography for measurement of left ventricular mass: in vivo anatomic validation using explanted human hearts. , 1997, Journal of the American College of Cardiology.

[11]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[12]  G. Reboldi,et al.  Prognostic significance of serial changes in left ventricular mass in essential hypertension. , 1998, Circulation.

[13]  P. Gosse,et al.  Is echocardiography an adequate method to evaluate left ventricular hypertrophy regression? , 1990, European heart journal.

[14]  M. Lipton,et al.  Canine left ventricular mass estimation by two-dimensional echocardiography. , 1983, Circulation.

[15]  D. Mirvis,et al.  Left ventricular hypertrophy: effect on survival. , 1993, Journal of the American College of Cardiology.

[16]  E. Geiser,et al.  Calculation of left ventricular mass and relative wall thickness. , 1974, Archives of pathology.

[17]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[18]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[19]  D. Pennell,et al.  Left Ventricular Hypertrophy With Exercise and ACE Gene Insertion/Deletion Polymorphism: A Randomized Controlled Trial With Losartan , 2001, Circulation.

[20]  P. Guéret,et al.  Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. HYCAR Study Group. , 1995, Hypertension.

[21]  J. Ghali,et al.  The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery Disease , 1992, Annals of Internal Medicine.

[22]  K. Pennert,et al.  Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. , 1992, American journal of hypertension.

[23]  Dudley J Pennell,et al.  Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance , 2002, Hypertension.

[24]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[25]  Bove Ke,et al.  Calculation of left ventricular mass and relative wall thickness. , 1974 .

[26]  R. Schmieder,et al.  Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents. , 1998, American journal of hypertension.

[27]  J. Kisslo,et al.  Validation of in vivo two-dimensional echocardiographic dimension measurements using myocardial mass estimates in dogs. , 1987, American heart journal.

[28]  J. Gottdiener,et al.  Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. , 1995, American journal of hypertension.

[29]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.